Tapewire

Nasdaq · USD

ADMA

ADMA BIOLOGICS, INC.

Export transactions ↓
Tapewire entity
4477
SEC CIK
0001368514
Parsed reports
254

Last 12 months

Inside the activity.

5 purchase rows · 9 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202600
Feb 202602
Mar 202623
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 06, 2023 Filed Mar 9, 2023 02:30 UTC
Grossman Adam SDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 1,147,385 $0.00 Strike: $3.35 $0.00
Disclosure

SEC source: 0001140361-23-010774 · form4.xml · derivative · entry 8

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,147,385

Underlying: Common Stock · 1,147,385 shares

Expires 2033-03-06

F6 · derivative.exercise_date: The options vest over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on March 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC
Grossman Adam SDirector · President and CEO
GrantCommon Stock 573,695 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-010774 · form4.xml · nonDerivative · entry 4

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,584,599

F1 · shares: Includes, as of the transaction date, (i) 573,695 RSUs granted on March 6, 2023 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 225,000 unvested RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 453,750 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC GrantEmployee Stock Option (right to buy) · Derivative 51,630 $0.00 Strike: $3.35 $0.00
Disclosure

SEC source: 0001140361-23-010772 · form4.xml · derivative · entry 6

Grossman Jerrold B · CIK 0001542519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,630

Underlying: Common Stock · 51,630 shares

Expires 2033-03-06

F7 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC GrantCommon Stock 25,815 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-010772 · form4.xml · nonDerivative · entry 1

Grossman Jerrold B · CIK 0001542519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,265

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 274,157 shares of common stock owned by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC GrantEmployee Stock Option (right to buy) · Derivative 51,630 $0.00 Strike: $3.35 $0.00
Disclosure

SEC source: 0001140361-23-010770 · form4.xml · derivative · entry 3

Guiheen Lawrence P. · CIK 0001554353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,630

Underlying: Common Stock · 51,630 shares

Expires 2033-03-06

F4 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC GrantCommon Stock 25,815 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-010770 · form4.xml · nonDerivative · entry 1

Guiheen Lawrence P. · CIK 0001554353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,901

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 90,793 shares of common stock owned by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC
KWON YOUNGDirector
GrantEmployee Stock Option (right to buy) · Derivative 51,630 $0.00 Strike: $3.35 $0.00
Disclosure

SEC source: 0001140361-23-010768 · form4.xml · derivative · entry 2

KWON YOUNG · CIK 0001733094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,630

Underlying: Common Stock · 51,630 shares

Expires 2033-03-06

F3 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC
KWON YOUNGDirector
GrantCommon Stock 25,815 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-010768 · form4.xml · nonDerivative · entry 1

KWON YOUNG · CIK 0001733094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,401

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 213,293 shares of common stock owned by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC
Fong BryantDirector
GrantEmployee Stock Option (right to buy) · Derivative 51,630 $0.00 Strike: $3.35 $0.00
Disclosure

SEC source: 0001140361-23-010767 · form4.xml · derivative · entry 3

Fong Bryant · CIK 0001542298 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,630

Underlying: Common Stock · 51,630 shares

Expires 2033-03-06

F4 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:30 UTC
Fong BryantDirector
GrantCommon Stock 25,815 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-010767 · form4.xml · nonDerivative · entry 1

Fong Bryant · CIK 0001542298 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,901

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 20,793 shares of common stock owned by the reporting person.

Read SEC document
February 28, 2023 Filed Mar 8, 2023 21:30 UTC
LENZ BRIANEVP, CFO
Tax withholdingCommon Stock 5,000 $3.55 $17,750.00
Disclosure

SEC source: 0001140361-23-010773 · form4.xml · nonDerivative · entry 3

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 906,117

Read SEC document
February 28, 2023 Filed Mar 9, 2023 02:30 UTC
Grossman Adam SDirector · President and CEO
Tax withholdingCommon Stock 7,507 $3.55 $26,649.85
Disclosure

SEC source: 0001140361-23-010774 · form4.xml · nonDerivative · entry 3

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,010,904

Read SEC document
February 25, 2023 Filed Mar 8, 2023 21:30 UTC
LENZ BRIANEVP, CFO
Tax withholdingCommon Stock 7,927 $3.42 $27,110.34
Disclosure

SEC source: 0001140361-23-010773 · form4.xml · nonDerivative · entry 2

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 911,117

Read SEC document
February 25, 2023 Filed Mar 8, 2023 21:30 UTC
LENZ BRIANEVP, CFO
Tax withholdingCommon Stock 1,559 $3.42 $5,331.78
Disclosure

SEC source: 0001140361-23-010773 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 919,044

Read SEC document
February 25, 2023 Filed Mar 9, 2023 02:30 UTC
Grossman Adam SDirector · President and CEO
Tax withholdingCommon Stock 14,412 $3.42 $49,289.04
Disclosure

SEC source: 0001140361-23-010774 · form4.xml · nonDerivative · entry 2

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,018,411

Read SEC document
February 25, 2023 Filed Mar 9, 2023 02:30 UTC
Grossman Adam SDirector · President and CEO
Tax withholdingCommon Stock 4,018 $3.42 $13,741.56
Disclosure

SEC source: 0001140361-23-010774 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,032,823

Read SEC document
January 04, 2023 Filed Jan 6, 2023 21:00 UTC
LENZ BRIANEVP, CFO
Tax withholdingCommon Stock 114,222 $3.87 $442,039.14
Disclosure

SEC source: 0001140361-23-000872 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 920,603

F1 · balance_after: Includes (i) 137,500 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 247,500 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which shall vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F2 · balance_after: (continued from footnote 1) (iii) 47,207 unvested RSUs granted on February 25, 2021, of which 41,250 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 5,957 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;

F3 · balance_after: (continued from footnote 2) (iv) 20,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 468,396 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
January 04, 2023 Filed Jan 7, 2023 02:00 UTC
Grossman Adam SDirector · President and CEO
Tax withholdingCommon Stock 166,867 $3.87 $645,775.29
Disclosure

SEC source: 0001140361-23-000873 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,036,841

F1 · balance_after: Includes (i) 300,000 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 453,750 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F2 · balance_after: (continued from footnote 1) (iii) 162,893 unvested RSUs granted on February 25, 2021, of which 137,362 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 25,531 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;

F3 · balance_after: (continued from footnote 2) (iv) 50,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 1,070,198 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
December 09, 2022 Filed Dec 9, 2022 16:41 UTC
LENZ BRIANEVP, CFO
PurchaseCommon Stock 6,993 $2.86 $19,999.98
Disclosure

SEC source: 0001140361-22-045112 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,034,825

F1 · shares: Represents a purchase from the underwriters in the December 2022 public offering of the issuer.

F2 · balance_after: Includes (i) 137,500 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 495,000 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F3 · balance_after: (iii) 47,207 unvested RSUs granted on February 25, 2021, of which 41,250 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 5,957 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;

F4 · balance_after: (iv) 20,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 335,118 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
December 09, 2022 Filed Dec 9, 2022 21:41 UTC
Grossman Adam SDirector · President and CEO
PurchaseCommon Stock 14,982 $2.86 $42,848.52
Disclosure

SEC source: 0001140361-22-045111 · form4.xml · nonDerivative · entry 2

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,143,426

F1 · shares: Represents a purchase from the underwriters in the December 2022 public offering of the issuer.

F5 · ownership.nature: These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.

Read SEC document
December 09, 2022 Filed Dec 9, 2022 21:41 UTC
Grossman Adam SDirector · President and CEO
PurchaseCommon Stock 14,983 $2.86 $42,851.38
Disclosure

SEC source: 0001140361-22-045111 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,203,708

F1 · shares: Represents a purchase from the underwriters in the December 2022 public offering of the issuer.

F2 · balance_after: Includes (i) 300,000 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 907,500 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (continued)

F3 · balance_after: (continued from prior footnote) (iii) 162,893 unvested RSUs granted on February 25, 2021, of which 137,362 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 25,531 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (continued)

F4 · balance_after: (continued from prior footnote) (iv) 50,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 783,315 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 21:01 UTC
LENZ BRIANEVP, CFO
Tax withholdingCommon Stock 73,678 $2.43 $179,037.54
Disclosure

SEC source: 0001140361-22-036163 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,027,832

F1 · balance_after: Includes (i) 137,500 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 495,000 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iii) 47,207 unvested RSUs granted on February 25, 2021, of which 41,250 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's (continued)

F2 · balance_after: (continued from prior footnote) continued service as of the applicable vesting date and 5,957 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (iv) 20,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 328,125 shares of common stock owned by the reporting person, which reflects previous purchases and prior net settlements upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
September 30, 2022 Filed Oct 5, 2022 01:21 UTC
Grossman Adam SDirector · President and CEO
Tax withholdingCommon Stock 101,315 $2.43 $246,195.45
Disclosure

SEC source: 0001140361-22-036164 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,188,725

F1 · balance_after: Includes (i) 300,000 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 907,500 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iii) 162,893 unvested RSUs granted on February 25, 2021, of which 137,362 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's (continued)

F2 · balance_after: (continued from prior footnote) continued service as of the applicable vesting date and 25,531 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (iv) 50,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 768,332 shares of common stock owned by the reporting person, which reflects previous purchases and prior net settlements upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:03 UTC
LENZ BRIANEVP, CFO
Tax withholdingCommon Stock 51,965 $1.43 $74,309.95
Disclosure

SEC source: 0001140361-22-019216 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,101,510

F1 · balance_after: Includes (i) 137,500 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 495,000 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iii) 180,225 unvested Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation of the

F2 · balance_after: (continued from footnote 1) Compensation Committee of the Board of Directors, which shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iv) 47,207 unvested RSUs granted on February 25, 2021, of which 41,250 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and

F3 · balance_after: (continued from footnote 2) 5,957 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (v) 20,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 221,578 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
May 11, 2022 Filed May 14, 2022 01:01 UTC
Grossman Adam SDirector · President and CEO
Tax withholdingCommon Stock 70,004 $1.43 $100,105.72
Disclosure

SEC source: 0001140361-22-019215 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,290,040

F1 · balance_after: Includes (i) 300,000 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 907,500 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iii) 330,412 unvested Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation of the

F2 · balance_after: (continued from footnote 1) Compensation Committee of the Board of Directors, which shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iv) 162,893 unvested RSUs granted on February 25, 2021, of which 137,362 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 25,531 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's

F3 · balance_after: (continued from footnote 2) continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (v) 50,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 539,234 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
March 23, 2022 Filed Mar 25, 2022 17:16 UTC
LENZ BRIANEVP, CFO
Tax withholdingCommon Stock 37,178 $1.46 $54,279.88
Disclosure

SEC source: 0001140361-22-011251 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,153,475

F1 · balance_after: Includes (i) 137,500 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 495,000 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iii) 315,090 unvested Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation

F2 · balance_after: (continued from footnote 1) of the Compensation Committee of the Board of Directors, of which (x) 134,865 of the Milestone-Based RSUs shall become vested upon the achievement of a 15% gross margin on BIVIGAM without intermediates by the end of the fourth quarter of 2022, and (y) 180,225 of the Milestone-Based RSUs shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iv) 47,207 unvested RSUs granted on February 25, 2021, of which 41,250 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and

F3 · balance_after: (continued from footnote 2) 5,957 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (v) 20,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 138,678 shares of common stock owned by the reporting person, which reflects shares previously purchased in the open market and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
March 23, 2022 Filed Mar 25, 2022 21:15 UTC
Grossman Adam SDirector · President and CEO
Tax withholdingCommon Stock 50,539 $1.46 $73,786.94
Disclosure

SEC source: 0001140361-22-011249 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,360,044

F1 · balance_after: Includes (i) 300,000 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 907,500 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iii) 577,665 unvested Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation of the

F2 · balance_after: (continued from footnote 1) Compensation Committee of the Board of Directors, of which (x) 247,253 of the Milestone-Based RSUs shall become vested upon the achievement of a 15% gross margin on BIVIGAM without intermediates by the end of the fourth quarter of 2022, and (y) 330,412 of the Milestone-Based RSUs shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (iv) 162,893 unvested RSUs granted on February 25, 2021, of which 137,362 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 25,531 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting

F3 · balance_after: (continued from footnote 2) 2. person's continued service as of the applicable vesting date and 25,531 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (v) 50,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 361,986 shares of common stock owned by the reporting person, which reflects shares previously purchased in the open market and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 17:58 UTC
LENZ BRIANEVP, CFO
GrantEmployee Stock Option (right to buy) · Derivative 275,000 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008673 · form4.xml · derivative · entry 2

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 275,000 shares

Expires 2032-03-07

F6 · derivative.exercise_date: The options vest over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on March 7, 2026.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 17:58 UTC
LENZ BRIANEVP, CFO
GrantCommon Stock 137,500 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008673 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,190,653

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes (i) 137,500 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 495,000 Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F3 · balance_after: (continue from footnote 2) (iii) 405,000 Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors, of which (x) 22.2% of the Milestone-Based RSUs shall become vested upon the completion of a debt refinancing which adds non-dilutive capital to the Company's balance sheet before or during the calendar year ending December 31, 2022, (y) 33.3% of the Milestone-Based RSUs shall become vested upon the achievement of a 15% gross margin on BIVIGAM without intermediates by the end of the fourth quarter of 2022, and (z) 44.5% of the Milestone-Based RSUs shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date

F4 · balance_after: (continue from footnote 3) (iv) 47,207 RSUs granted on February 25, 2021, of which 41,250 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 5,957 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting; (v) 20,000 RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and

F5 · balance_after: (continue from footnote 4) (vi) 85,946 shares of common stock owned by the reporting person, which reflects shares previously purchased in the open market and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC GrantEmployee Stock Option (right to buy) · Derivative 53,172 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008672 · form4.xml · derivative · entry 2

DEMSKI MARTHA J · CIK 0001198230 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,172

Underlying: Common Stock · 53,172 shares

Expires 2032-03-07

F4 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC GrantCommon Stock 26,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008672 · form4.xml · nonDerivative · entry 1

DEMSKI MARTHA J · CIK 0001198230 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 30,786

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 4,200 shares of common stock owned by the reporting person.

F3 · ownership.nature: These shares are held in the trust account of the Martha J. Demski Trust U/D/T 10/01/94, for which the reporting person serves as trustee.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 17:59 UTC
ELMS STEVEDirector
GrantEmployee Stock Option (right to buy) · Derivative 53,172 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008676 · form4.xml · derivative · entry 3

ELMS STEVE · CIK 0001250195 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,172

Underlying: Common Stock · 53,172 shares

Expires 2032-03-07

F4 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 17:59 UTC
ELMS STEVEDirector
GrantCommon Stock 26,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008676 · form4.xml · nonDerivative · entry 1

ELMS STEVE · CIK 0001250195 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,586

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1).

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:59 UTC
KWON YOUNGDirector
GrantEmployee Stock Option (right to buy) · Derivative 53,172 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008677 · form4.xml · derivative · entry 2

KWON YOUNG · CIK 0001733094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,172

Underlying: Common Stock · 53,172 shares

Expires 2032-03-07

F3 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:59 UTC
KWON YOUNGDirector
GrantCommon Stock 26,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008677 · form4.xml · nonDerivative · entry 1

KWON YOUNG · CIK 0001733094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,586

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 200,000 shares of common stock owned by the reporting person.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:59 UTC GrantEmployee Stock Option (right to buy) · Derivative 53,172 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008675 · form4.xml · derivative · entry 3

Guiheen Lawrence P. · CIK 0001554353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,172

Underlying: Common Stock · 53,172 shares

Expires 2032-03-07

F4 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:59 UTC GrantCommon Stock 26,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008675 · form4.xml · nonDerivative · entry 1

Guiheen Lawrence P. · CIK 0001554353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,086

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 77,500 shares of common stock owned by the reporting person.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC
Fong BryantDirector
GrantEmployee Stock Option (right to buy) · Derivative 53,172 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008674 · form4.xml · derivative · entry 3

Fong Bryant · CIK 0001542298 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,172

Underlying: Common Stock · 53,172 shares

Expires 2032-03-07

F4 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC
Fong BryantDirector
GrantCommon Stock 26,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008674 · form4.xml · nonDerivative · entry 1

Fong Bryant · CIK 0001542298 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,086

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 7,500 shares of common stock owned by the reporting person.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC
Grossman Adam SDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 600,000 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008671 · form4.xml · derivative · entry 4

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2032-03-07

F8 · derivative.exercise_date: The options vest over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on March 7, 2026.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC
Grossman Adam SDirector · President and CEO
GrantCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008671 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,410,583

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes (i) 300,000 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 907,500 Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F3 · balance_after: (continue from footnote 2) (iii) 742,500 Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors, of which (x) 22.2% of the Milestone-Based RSUs shall become vested upon the completion of a debt refinancing which adds non-dilutive capital to the Company's balance sheet before or during the calendar year ending December 31, 2022, (y) 33.3% of the Milestone-Based RSUs shall become vested upon the achievement of a 15% gross margin on BIVIGAM without intermediates by the end of the fourth quarter of 2022, and (z) 44.5% of the Milestone-Based RSUs shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting,

F4 · balance_after: (continue from footnote 3) subject to the reporting person's continued employment on the applicable vesting date; (iv) 162,893 unvested RSUs granted on February 25, 2021, of which 137,362 RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 25,531 RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;

F5 · balance_after: (continue from footnote 4) (v) 50,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 247,690 shares of common stock owned by the reporting person, which reflects shares previously purchased in the open market and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC GrantEmployee Stock Option (right to buy) · Derivative 53,172 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001140361-22-008670 · form4.xml · derivative · entry 6

Grossman Jerrold B · CIK 0001542519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,172

Underlying: Common Stock · 53,172 shares

Expires 2032-03-07

F7 · derivative.exercise_date: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:58 UTC GrantCommon Stock 26,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-008670 · form4.xml · nonDerivative · entry 1

Grossman Jerrold B · CIK 0001542519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,450

F1 · shares: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.

F2 · balance_after: Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 260,864 shares of common stock owned by the reporting person.

Read SEC document
October 25, 2021 Filed Oct 26, 2021 07:00 UTC
LENZ BRIANEVP, CFO
PurchaseCommon Stock 30,000 $1.00 $30,000.00
Disclosure

SEC source: 0001140361-21-035380 · form4.xml · nonDerivative · entry 1

LENZ BRIAN · CIK 0001283260 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,065,501

F1 · shares: Represents a purchase from the underwriters in the October 2021 public offering of the issuer.

F2 · balance_after: Includes (i) 495,000 Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F3 · balance_after: (ii) 405,000 Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors, of which (x) 22.2% of the Milestone-Based RSUs shall become vested upon the completion of a debt refinancing which adds non-dilutive capital to the Company's balance sheet before or during the calendar year ending December 31, 2022, (y) 33.3% of the Milestone-Based RSUs shall become vested upon the achievement of a 15% gross margin on BIVIGAM without intermediates by the end of the fourth quarter of 2022, and (z) 44.5% of the Milestone-Based RSUs shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F4 · balance_after: (iii) 63,936 RSUs granted on February 25, 2021, of which 55,000 RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 8,936 RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;

F5 · balance_after: (iv) 30,000 RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 71,565 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
October 25, 2021 Filed Oct 26, 2021 11:00 UTC
KWON YOUNGDirector
PurchaseCommon Stock 100,000 $1.00 $100,000.00
Disclosure

SEC source: 0001140361-21-035382 · form4.xml · nonDerivative · entry 1

KWON YOUNG · CIK 0001733094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

F1 · shares: Represents a purchase from the underwriters in the October 2021 public offering of the issuer.

Read SEC document
October 25, 2021 Filed Oct 26, 2021 11:00 UTC PurchaseCommon Stock 100,000 $1.00 $100,000.00
Disclosure

SEC source: 0001140361-21-035381 · form4.xml · nonDerivative · entry 1

Grossman Jerrold B · CIK 0001542519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,864

F1 · shares: Represents a purchase from the underwriters in the October 2021 public offering of the issuer.

Read SEC document
October 25, 2021 Filed Oct 26, 2021 11:00 UTC
Grossman Adam SDirector · President and CEO
PurchaseCommon Stock 250,000 $1.00 $250,000.00
Disclosure

SEC source: 0001140361-21-035379 · form4.xml · nonDerivative · entry 2

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,128,444

F1 · shares: Represents a purchase from the underwriters in the October 2021 public offering of the issuer.

F6 · ownership.nature: These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.

Read SEC document
October 25, 2021 Filed Oct 26, 2021 11:00 UTC
Grossman Adam SDirector · President and CEO
PurchaseCommon Stock 100,000 $1.00 $100,000.00
Disclosure

SEC source: 0001140361-21-035379 · form4.xml · nonDerivative · entry 1

Grossman Adam S · CIK 0001542517 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,137,616

F1 · shares: Represents a purchase from the underwriters in the October 2021 public offering of the issuer.

F2 · balance_after: Includes (i) 907,500 Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs"), of which (x) 50% of the Time Based RSUs shall vest on December 31, 2022 ("Initial Vesting Date") and (y) 50% of the Time-Based RSUs shall vest in eight (8) equal quarterly installments over a period of two years following the Initial Vesting Date, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F3 · balance_after: (ii) 742,500 Milestone-Based RSUs granted on September 29, 2021, subject to milestone-based vesting conditions (the "Milestone-Based RSUs") established by the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors, of which (x) 22.2% of the Milestone-Based RSUs shall become vested upon the completion of a debt refinancing which adds non-dilutive capital to the Company's balance sheet before or during the calendar year ending December 31, 2022, (y) 33.3% of the Milestone-Based RSUs shall become vested upon the achievement of a 15% gross margin on BIVIGAM without intermediates by the end of the fourth quarter of 2022, and (z) 44.5% of the Milestone-Based RSUs shall become vested upon the achievement of $35 million in quarterly revenues in or before the fourth quarter of 2022 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;

F4 · balance_after: (iii) 221,447 RSUs granted on February 25, 2021, of which 183,150 RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 38,297 RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;

F5 · balance_after: (iv) 75,000 RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 191,169 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Read SEC document
October 15, 2021 Filed Oct 18, 2021 22:21 UTC
KWON YOUNGDirector
GrantStock Option (right to buy) · Derivative 93,500 $0.00 Strike: $1.10 $0.00
Disclosure

SEC source: 0001140361-21-034767 · form4.xml · derivative · entry 1

KWON YOUNG · CIK 0001733094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,500

Underlying: Common Stock · 93,500 shares

Expires 2031-10-15

F1 · derivative.exercise_date: Reflects the grant of a stock option to purchase 93,500 shares of common stock, $0.0001 par value per share ("Common Stock") of ADMA Biologics, Inc. The shares of Common Stock underlying the stock option will vest in 12 equal monthly installments, becoming fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service on the applicable vesting date.

Read SEC document
September 30, 2021 Filed Sep 30, 2021 23:27 UTC SaleCommon Stock 137,495 $1.12 $153,994.40
Disclosure

SEC source: 0001062993-21-009017 · form4.xml · nonDerivative · entry 3

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 13,262,375

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.15, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.